SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001213900-21-039868
Filing Date
2021-08-02
Accepted
2021-08-02 17:08:46
Documents
8

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 posam2021_180lifesciences.htm POS AM 8469621
2 OPINION OF PRYOR CASHMAN LLP posam2021ex5-1_180lifesci.htm EX-5.1 10425
3 CONSENT OF WITHUMSMITH+BROWN, PC, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM posam2021ex23-1_180lifesci.htm EX-23.1 2375
4 GRAPHIC timage_001.jpg GRAPHIC 582564
5 GRAPHIC timage_002.jpg GRAPHIC 266736
6 GRAPHIC timage_003.jpg GRAPHIC 90966
7 GRAPHIC tflowchart_001.jpg GRAPHIC 615108
8 GRAPHIC ex5-2_001.jpg GRAPHIC 28600
  Complete submission text file 0001213900-21-039868.txt   10665695
Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-249539 | Film No.: 211136876
SIC: 2834 Pharmaceutical Preparations